Patients, providers, payers, and regulators should consider this best practice framework when assessing the validity of VR treatments.
No takes yet. Share an insight, caveat, or question.
Birckhead et al. (2018) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: